Abelson RP, Levi A. 1985. Decision making and decision theory. In Handbook of Social Psychology, p. 231. New York: Random House.
Agency for Healthcare Research and Quality (AHRQ). 2001. Medical Errors: The Scope of the Problem. Rockville, MD, AHRQ.
American Pharmacists Association (APhA). 2003. American Pharmacists Association Catalogue. Washington, DC: APhA.
Anonymous. 2002.
Root Cause Analysis. Washington, DC:
VA National Center for Patient Safety.
Anonymous. 2003a. The Big Picture. Talkingquality.gov.
Anonymous. 2003b. Performance Measures in Health Care. Washington, DC: Joint Commission on Accreditation of Healthcare Organizations.
Arizona Revised Statutes. 2007. Amending Title 32, Chapter 18, Article 3, Arizona Revised Statutes, by adding 32–1973, relating to the state board of pharmacy.
Bagian JP, Lee C, Gosbee J, et al. 2001. Developing and deploying a patient safety program in a large health care delivery system: You can't fix what you don't know about. Joint Comm J Qual Improv 27:522.
Blumenthal D, Kilo CM. 1998. A report card on continuous quality improvement. Milbank Q 76:625.
Bluml BM, McKenney JM, Cziraki MJ, et al. 2000. Pharmaceutical care services and results in project ImPACT: Hyperlipidemia. J Am Pharm Assoc 40:157.
Boeing. 1993. Accident Prevention Strategies: Removing Links in the Accident Chain. Seattle: Boeing Commercial Airplane Group.
Carayon P, Schoofs-Hundt A, Karsh BT, Gurses AP, et al. 2006. Work system design for patient safety: the SEIPS model. Qual Saf Health Care 15 Suppl 1:i50–8.
Chassin MR, Galvin RW. 1998. The urgent need to improve health care quality. Institute of Medicine National Roundtable on health care quality. JAMA 280:1000–5
Clearinghouse NG. 2000. Evidence-based clinical practice guidelines. Agency for Healthcare Research and Quality. Available at
www.qualitymeasures.ahrq.gov/; accessed on May 28, 2011.
Clifford RM, Davis WA, Batty KT, et al. 2005. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: The Fremantle diabetes study. Diabetes Care 28:771–6.
Coe CP. 1998a. An overview of the Joint Commission's improving organizational performance standards. In Preparing the Pharmacy for a Joint Commission Survey, p. 189. Bethesda, MD: ASHP.
Coe CP. 1998b. Overview of the Joint Commission's Sentinel Event Policy. In Preparing the Pharmacy for a Joint Commission Survey, p. 200. Bethesda, MD: ASHP.
Coe CP. 1998c. Joint Commission on Accreditation of Healthcare Organizations. In Preparing the Pharmacy for a Joint Commission Survey, p. 1. Bethesda, MD: ASHP.
Cohen MR, Senders J, Davis NM. 1994. Failure mode and effects analysis: A novel approach to avoiding dangerous medication errors and accidents. Hosp Pharm 29: 319.
Congress of the United States, Office of Technology Assessment. 1988. The Quality of Medical Care: Information for Consumers, p. x. Washington, DC: U.S. Government Printing Office.
Cordina M, McElnay JC, Hughes CM. 2001. Assessment of a community pharmacy-based program for patients with asthma. Pharmacotherapy 21:1196–203.
Cranor CW, Bunting BA, Christensen DB, 2003. The Asheville Project: Long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc 43:173.
Dedden P, Chang B, Nagel D, 1997. Pharmacy-managed program for home treatment of deep vein thrombosis with
enoxaparin.
Am J Health-Syst Pharm 54:1968.
Deming WE. 1986. Out of the Crisis. Cambridge, MA: Massachusetts Institute of Technology, Center for Advanced Engineering Study.
DeRosier J, Stalhandske E, Bagian JP, et al. 2002. Using health care failure mode and effect analysis: The
VA National Center for Patient Safety's prospective risk analysis system.
Joint Comm J Qual Improv 28:248.
Donabedian A. 1969. Quality of care: Problems of measurement: II. Some issues in evaluating the quality of nursing care. Am J Public Health Nations Health 59:1833.
Donabedian A. 1991. Quality assurance: Structure, process, and outcome. Nurs Stand 7:4.
Federal Aviation Authority (FAA). 1993. Human Factor Policy. Washington: US Department of Transportation.
Fertleman M, Barnett N, Patel T, 2005. Improving medication management for patients: The effect of a pharmacist on post-admission ward rounds. Qual Saf Health Care 14:207–11.
Garrett DG, Bluml BM. 2005. Patient self-management program for diabetes: First-year clinical, humanistic, and economic outcomes. J Am Pharm Assoc 45:130–7.
Godwin HN, Sanborn MD. 1995. Total quality management in hospital pharmacy. Am Pharm NS35:51.
Gosbee J, Anderson T. 2003. Human factors engineering design demonstrations can enlighten your RCA team. Qual Saf Health Care 12:119.
Hansen LB, Fernald D, Akaya-Guerra R, et al. 2006. Pharmacy clarification of prescriptions ordered in primary care: A report from the Applied Strategies for Improving Patient Safety (ASIPS) collaborative. J Am Board Fam Med 19:24–30.
Hume M. 1999. Changing hospital culture, systems reduces drug errors. Exec Solutions Healthcare Manag 2:1.
Johnson ST, Brown GC, Shea KM, 2002. Reengineering a pharmacist intervention program. Am J Health-Syst Pharm 59:916.
Kiel PJ, McCord AD. 2005. Pharmacist impact on clinical outcomes in a diabetes disease management program via collaborative practice. Ann Pharmacother 39:1828–32.
Kohn L. 2000. To err is human: An interview with the Institute of Medicine's Linda Kohn. Joint Comm J Qual Improv 26:227.
Kozma CM, Reeder CE, Schultz RM, 1993. Economic, clinical and humanistic outcomes: A planning model for pharmacoeconomic research. Clin Ther 15:1121.
Krass I, Taylor SJ, Smith C, et al. 2005. Impact on mediation use and adherence of Australian pharmacists' diabetes care services. J Am Pharm Assoc 45:33–40.
Lazarus IR, Butler K. 2001. The promise of six sigma, part 1. Manag Healthcare Exec 10:22.
Lazarus IR, Stamps B. 2002. The promise of six sigma, part 2. Manag Healthcare Exec 1:27.
Leal S, Herrier RN, Glover JJ, Felix A. 2004. Improving quality of care in diabetes through a comprehensive pharmacist-based disease management program. Diabetes Care 27:2983–4.
Leape LL. 1994. Error in medicine. JAMA 272:1851.
Leape LL, Kabcenell A, Berwick DM, et al. 1998a. Change concepts for reducing adverse drug events. In Reducing Adverse Drug Events: Breakthrough Series Guide, p. 49. Boston: Institute for Healthcare Improvement.
Leape LL, Kabcenell A, Berwick DM, et al. 1998b. Achieving breakthrough improvement in reducing adverse drug events. In Reducing Adverse Drug Events: Breakthrough Series Guide, p. 79. Boston: Institute for Healthcare Improvement.
Leape LL, Kabcenell A, Berwick DM, et al. 1998c. A step-by-step guide to reducing adverse drug events. In Reducing Adverse Drug Events: Breakthrough Series Guide. Boston: Institute for Healthcare Improvement, p. 13.
Lee JK, Grace KA, Taylor AJ, 2006. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: A randomized, controlled trial (see Comment). JAMA 296:2563–71.
Lohr KE. 1990a. Health, health care, and quality of care. In Medicare: A Strategy for Quality Assurance. Washington, DC: National Academy Press, p. 19.
Lohr KE. 1990b. Concepts of assessing, assuring, and improving quality. In Medicare: A Strategy for Quality Assurance. Washington, DC: National Academy Press, p. 45.
Lovern E. 2001. Minding hospitals' business: Purchasing coalition pushes hospitals to improve patient safety through process measures, but industry says standards are too expensive. Mod Healthcare 31:30.
Mangiapane S, Schulz M, et al. 2005. Community pharmacy-based pharmaceutical care for asthma patients. Ann Pharmacother 39:1817–22.
Merriam-Webster. 2003. Merriam-Webster Dictionary. Springfield, MA: Merriam-Webster.
Nagel DC. 1988. Human error in aviation operations. In Nagel DC (ed), Human Factors in Aviation, p. 263. New York: Academic Press.
National Committee for Quality Assurance (NCQA). 2003. NCQA Overview. Washington, DC: NCQA.
Nolan TW. 2000. System changes to improve patient safety. Br Med J 320:771.
O'Malley C. 1997. Quality measurement for health systems: Accreditation and report cards. Am J Health-Syst Pharm 54:1528.
Ovretveit J. 1992. Health Service Quality. Oxford, England: Blackwell Scientific.
Ovretveit J. 2001. Quality evaluation and indicator comparison in health care. Int J Health Plan Manag 16:229.
Park KS. 1997. Human error. In Salvendy G (ed), Handbook of Human Factors and Ergonomics. New York: Wiley-Interscience, p. 150.
Pharmacy Quality Alliance (PQA). 2011a. PQA. Available at
www.PQAAlliance.org; accessed on June 13, 2011.
Pharmacy Quality Alliance (PQA). 2011c. EPIQ Flier. Available at www.pqaalliance.org/files/EPIQ-Flyer_MAR 2010.pdf; accessed on June 13, 2011.
Ragucci KR, Fermo JD, Wessell AM, et al. 2005. Effectiveness of pharmacist-administered diabetes mellitus education and management services. Pharmacotherapy 25:1809–16.
Rasmussen J, Pejtersen AM, Goodstein LP, 1994. Cognitive Systems Engineering. New York: Wiley.
Rogers B. 1997. Preventing medication errors. Healthplan 38:27.
Rupp MT, McCallian DJ, Sheth KK, 1997. Developing and marketing a community pharmacy-based asthma management program. J Am Pharm Assoc NS37:694.
Sadik A, Yousif M, McElnay JC, 2005. Pharmaceutical care of patients with heart failure. Br J Clin Pharmacol 60:183–93.
Schnipper JL, Kirwin JL, Cotugno MC, et al. 2006. Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med 166:565–71.
Schulz M, Verheyen F, Muhlig S, et al. 2001. Pharmaceutical care services for asthma patients: A controlled intervention study. J Clin Pharmacol 41:668–76.
Scott DM, Boyd ST, Stephan M, et al. 2006. Outcomes of pharmacist-managed diabetes care services in a community health center. Am J Health-Syst Pharm 63:2116–22.
Shane R, Gouveia WA. 2000. Developing a strategic plan for quality in pharmacy practice. Am J Health-Syst Pharm 57:470.
Sheridan TB. 1988. The system perspective. In Nagel DC (ed), Human Factors in Aviation. New York: Academic Press, p. 27.
Shortell SM, Bennett CL, Byck GR, 1998. Assessing the impact of continuous quality improvement on clinical practice: What it will take to accelerate progress. Milbank Q 76:593.
Shortell SM, O'Brien JL, Hughes EF, et al. 1994. Assessing the progress of TQM in U.S. hospitals: Findings from two studies. Q Lett Healthcare Lead 6:14.
Sookaneknun P, Richards RM, Sanguansermsri J, et al. 2004. Pharmacist involvement in primary care improves hypertensive patient clinical outcomes. Ann Pharmacother 38:2023–8.
van Bokhoven MA, Kok G, Vander Weijden T, 2003. Designing a quality improvement intervention: A systematic approach. Qual Saf Health Care 12:215.
Vrijens B, Belmans A, Matthys K, et al. 2006. Effect of intervention through a pharmaceutical care program on patient adherence with prescribed once-daily
atorvastatin.
Pharmacoepidemiol Drug Saf 15:115–21.
von Bertalanffy L. 1968. General Systems Theory: Foundations, Development, Application. New York: George Braziller.
Warholak-Juarez T, Rupp MT, Salazar TA, et al. 2000. Effect of patient information on the quality of pharmacists' drug use review decisions. J Am Pharm Assoc 40:500.
Weinberger M, Murray MD, Marrero DG, et al. 2002. Effectiveness of pharmacist care for patients with reactive airways disease: A randomized, controlled trial (see Comment). JAMA 288:1594–602.
Weinstein MC, Fineberg HV. 1980. Clinical Decision Analysis. Philadelphia: Saunders.